Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × adavosertib × Clear all

NCT05212025 2022-06-14

Adavosertib and Gemcitabine in Advanced Pancreatic

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms